Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1968 1
1969 1
1971 2
1972 4
1973 5
1974 7
1975 16
1976 8
1977 17
1978 14
1979 20
1980 16
1981 15
1982 10
1983 17
1984 14
1985 16
1986 21
1987 11
1988 13
1989 11
1990 13
1991 17
1992 9
1993 12
1994 8
1995 9
1996 10
1997 10
1998 5
1999 4
2000 9
2001 5
2002 8
2003 6
2004 9
2005 9
2006 9
2007 3
2008 5
2009 3
2010 3
2011 9
2012 6
2013 5
2014 1
2015 1
2016 4
2017 2
2019 1
2020 2
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

435 results
Results by year
Filters applied: . Clear all
Page 1
Memory B and T cells.
Vitetta ES, Berton MT, Burger C, Kepron M, Lee WT, Yin XM. Vitetta ES, et al. Annu Rev Immunol. 1991;9:193-217. doi: 10.1146/annurev.iy.09.040191.001205. Annu Rev Immunol. 1991. PMID: 1910676 Review.
Immunotoxins.
Vitetta ES, Uhr JW. Vitetta ES, et al. Annu Rev Immunol. 1985;3:197-212. doi: 10.1146/annurev.iy.03.040185.001213. Annu Rev Immunol. 1985. PMID: 3904769 Review. No abstract available.
Immunotoxins: magic bullets or misguided missiles?
Vitetta ES, Thorpe PE, Uhr JW. Vitetta ES, et al. Trends Pharmacol Sci. 1993 May;14(5):148-54. doi: 10.1016/0165-6147(93)90199-t. Trends Pharmacol Sci. 1993. PMID: 8212309 Review.
Ricin vaccine development.
Smallshaw JE, Vitetta ES. Smallshaw JE, et al. Among authors: vitetta es. Curr Top Microbiol Immunol. 2012;357:259-72. doi: 10.1007/82_2011_156. Curr Top Microbiol Immunol. 2012. PMID: 21805396 Review.
Mucoricin is a ricin-like toxin that is critical for the pathogenesis of mucormycosis.
Soliman SSM, Baldin C, Gu Y, Singh S, Gebremariam T, Swidergall M, Alqarihi A, Youssef EG, Alkhazraji S, Pikoulas A, Perske C, Venkataramani V, Rich A, Bruno VM, Hotopp JD, Mantis NJ, Edwards JE Jr, Filler SG, Chamilos G, Vitetta ES, Ibrahim AS. Soliman SSM, et al. Among authors: vitetta es. Nat Microbiol. 2021 Mar;6(3):313-326. doi: 10.1038/s41564-020-00837-0. Epub 2021 Jan 18. Nat Microbiol. 2021. PMID: 33462434 Free PMC article.
Engineering therapeutic monoclonal antibodies.
Liu XY, Pop LM, Vitetta ES. Liu XY, et al. Among authors: vitetta es. Immunol Rev. 2008 Apr;222:9-27. doi: 10.1111/j.1600-065X.2008.00601.x. Immunol Rev. 2008. PMID: 18363992 Review.
Immunotoxins: an update.
Thrush GR, Lark LR, Clinchy BC, Vitetta ES. Thrush GR, et al. Among authors: vitetta es. Annu Rev Immunol. 1996;14:49-71. doi: 10.1146/annurev.immunol.14.1.49. Annu Rev Immunol. 1996. PMID: 8717507 Review.
Endosymbiosis: infection and cure.
Guttman HN, Vitetta ES. Guttman HN, et al. Among authors: vitetta es. Yale J Biol Med. 1967 Dec;40(3):183-91. Yale J Biol Med. 1967. PMID: 4869095 Free PMC article. Review. No abstract available.
Immunotherapy of multiple myeloma.
Huang YW, Vitetta ES. Huang YW, et al. Among authors: vitetta es. Stem Cells. 1995 Mar;13(2):123-34. doi: 10.1002/stem.5530130204. Stem Cells. 1995. PMID: 7540468 Free article. Review.
435 results